Direct Acting Antiviral and Glycemic Control In Patients with Hepatitis C (original) (raw)

Hepatitis C Treatment by Directly Acting Antiviral Agents and Its Impact on Glycemic Control

Journal of Pharmaceutical Research, 2021

Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control

Mohamed El-badry

Egyptian Liver Journal, 2020

View PDFchevron_right

Over time evaluation of glycaemic control in direct‐acting antiviral‐treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis

Irene Cacciola

Liver International, 2021

View PDFchevron_right

Treatment of Chronic Hepatitis C Can Improve Glycemic Control in Patients with Type 2 Diabetes

Meltem Sertbas

Case Reports in Hepatology

View PDFchevron_right

Evaluating the Effects of Anti-Viral Therapy on Insulin Resistance and Diabetic Status in Chronic Hepatitis C patients

Fadia Mostafa

Afro-Egyptian Journal of Infectious and Endemic Diseases, 2020

View PDFchevron_right

Poor glycemic control and abrupt onset of diabetes in HCV patients receiving direct-acting antiviral drugs: case series

Muhammad Waqar

Future Virology, 2018

View PDFchevron_right

Rapid Decline of Fasting Glucose in HCV Diabetic Patients Treated with Direct Acting Antiviral Agents

I. Mezzaroma

Clinical Microbiology and Infection, 2016

View PDFchevron_right

The Effect of Viral Clearance Achieved by Direct-Acting Antiviral Agents on Hepatitis C Virus Positive Patients with Type 2 Diabetes Mellitus: A Word of Caution after the Initial Enthusiasm

Marco Sacco

Journal of Clinical Medicine

View PDFchevron_right

Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents

Marco Sacco

Journal of Medical Virology

View PDFchevron_right

Impact of Direct Acting Antivirals for Treatment of Chronic Hepatitic C Virus Infection on Glycemic Control in Egyptian Patients with Type 2 Diabetes Mellitus

Arafat Kassem

View PDFchevron_right

Glucose and Lipid Profile Changes in Hepatitis C Patients After Direct Acting Antivirals Therapy

Mohamed Sharaf-Eldin

International Journal of TROPICAL DISEASE & Health, 2021

View PDFchevron_right

Insulin resistance does not impair response of chronic hepatitis C virus to direct-acting antivirals, and improves with the treatment

Mohamed Hashim

European journal of gastroenterology & hepatology, 2018

View PDFchevron_right

The impact of direct-acting antiviral treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients: temporary? permanent?

Engin Altintas

The Turkish journal of gastroenterology, 2020

View PDFchevron_right

Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c

Steven-huy Han

World Journal of Hepatology, 2018

View PDFchevron_right

Effect of Direct-Acting Antivirals on Lipid and Glucose Metabolism in Chronic HCV Patients

Dr.Mohammed Mohammed

Minia Journal of Medical Research, 2019

View PDFchevron_right

Insulin Resistance Reduction After Sustained Virological Response with Direct Acting Antiviral:Not Every Population Improves

Fábio Yamashiro

Arquivos de Gastroenterologia

View PDFchevron_right

Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals

Mária Szántová

View PDFchevron_right

Impact of Successful HCV Eradication on Glycemic Control in Chronic HCV Patients with Type II Diabetes Mellitus

azhar ali khan

Pakistan Journal of Medical and Health Sciences

View PDFchevron_right

Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents

Carlo Smirne

PLOS ONE

View PDFchevron_right

Time-course of insulin resistance during antiviral therapy in non-diabetic non-cirrhotic patients with genotype 1 HCV infection

Giulio Marchesini

Digestive and Liver Disease, 2009

View PDFchevron_right

The impact of a successful treatment of HCV on glyco-metabolic control in diabetic patients

Giulia Mosini

Antiviral Therapy

View PDFchevron_right

Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy

Martin Janičko

Canadian Journal of Gastroenterology & Hepatology, 2018

View PDFchevron_right

Change in insulin resistance according to virological response during antiviral treatment for hepatitis C virus infection

Jawtown Lin

Advances in Digestive Medicine, 2016

View PDFchevron_right

Metabolic Impact of Diabetes Mellitus Type 2 in Hepatitis C Virus Infected Patients

ADINA KAMAL

Current Health Sciences Journal, 2021

View PDFchevron_right

Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3

James Kench

Journal of Hepatology, 2008

View PDFchevron_right

Sustained Virological Response Correlates With Reduction in the Incidence of Glucose Abnormalities in Patients With Chronic Hepatitis C Virus Infection

Cristina Hernandez

Diabetes Care, 2006

View PDFchevron_right

Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C

Gian Luigi Prati

Hepatology, 2012

View PDFchevron_right

Metabolic changes in chronic hepatitis C patients receiving direct acting antivirals

Kadry Elsaeed

F1000Research

View PDFchevron_right

Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C

Santiago Durán

Journal of Hepatology, 2008

View PDFchevron_right

Direct Acting Antiviral and Glycemic Control In Patients with Hepatitis C (original) (raw)

Related papers